Eric Van Setten
Vice President of Investor and Public Relations
Replay available
Atossa Therapeutics, Inc. (ATOS) Q2 2023 Earnings Call
Atossa Therapeutics, Inc. (NASDAQ: ATOS) Q2 2023 earnings conference call, held 2023-08-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Stephen Quagg
President and Chief Executive Officer
Greg Weaver
Executive Vice President and Chief Financial Officer
Jason McCarthy
Analyst, Baxam Group
Michael Kunowich
Analyst (asking questions on behalf of Jason McCarthy)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Atossa Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.009 -- 00:00:03.290 Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Atosa 00:00:03.290 -- 00:00:07.791 Therapeutics Q2 2023 conference call. Please be advised, today's conference is being 00:00:07.791 -- 00:00:11.792 recorded. I would now like to hand the conference over to your first speaker today, Eric 00:00:11.792 -- 00:00:15.773 Van Setten, Vice President of Investor and Public Relations. 00:00:15.773 -- 00:00:19.113 Mr. Van Setten, you may begin. 00:00:19.433 -- 00:00:23.354 Thank you, Kevin. Good morning, everyone, and welcome to Atosa's second quarter 2023 00:00:23.354 -- 00:00:26.866 Corporate and Financial Update conference call. 00:00:26.866 -- 00:00:30.409 Earlier this morning, we issued a press release providing an overview of our recent corporate 00:00:30.409 -- 00:00:34.231 highlights and financial results for the quarter ended June 30th, 2023. 00:00:34.231 -- 00:00:40.955 The press release can be accessed on the investor portion of our website at investors.atosatherapeutics.com. 00:00:43.298 -- 00:00:47.421 Joining me on the call today are Dr. Stephen Quagg, Atosa's President and Chief Executive 00:00:47.421 -- 00:00:53.205 Officer, and Greg Weaver, our Executive Vice President and Chief Financial Officer. 00:00:53.205 -- 00:00:56.874 During today's call, we will be making certain forward-looking statements. 00:00:56.874 -- 00:01:01.158 which are subject to risks and uncertainties that may cause actual results to differ 00:01:01.158 -- 00:01:05.541 materially from the anticipated or estimated future results. 00:01:05.541 -- 00:01:10.125 These forward-looking statements are based on current information, assumptions, and expectations 00:01:10.125 -- 00:01:14.789 that are subject to change. The description...